Protective effects of antidepressants against chronic fatigue syndrome - Induced behavioral changes and biochemical alterations

Fundamental and Clinical Pharmacology

Volumn 23, Issue 1, 2009, Pages 89-95

  Kumar, Anil ^a   Garg, Ruchika ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antidepressants; Chronic fatigue; Forced swimming test; Oxidative stress

Indexed keywords

ANTIDEPRESSANT AGENT; CATALASE; CITALOPRAM; DESIPRAMINE; GLUTATHIONE; IMIPRAMINE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CHEMICAL ANALYSIS; CHRONIC FATIGUE SYNDROME; CHRONIC STRESS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MOUSE; IMMOBILIZATION; LIPID PEROXIDATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; CITALOPRAM; DESIPRAMINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE SYNDROME, CHRONIC; IMIPRAMINE; LIPID PEROXIDATION; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; OXIDATIVE STRESS; SWIMMING;

EID: 61349112061     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2008.00638.x     Document Type: Article

References (45)

1. Devanur L.D., Kerr J.R. Chronic fatigue syndrome. J. Clin. Virol. (2006) 37 139 150.
2. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. (1994) 121 953 959.
3. Chambers D., Bagnall A.M., Hempel S., Forbes C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J. R. Soc. Med. (2006) 99 506 520.
4. McEven B.S., Sapolsky R.M. Stress and cognitive function. Curr. Opin. Neurobiol. (1995) 5 205 216.
5. Checkley S. Neuroendocrine mechanisms and the precipitation of depression by life events. Br. J. Psychiatr. (1992) 5 7 17.
6. Sapolsky R.M. Why stress is bad for your brain. Science (1996) 273 749 750.
7. Fulle S., Mecocci P., Fano G. Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radic. Biol. Med. (2000) 29 1252 1259.
8. Richards R.S., Roberts T.K., Mc Gregor N.R., Dunstan R.H., Butt H.L. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. (2000) 5 35 41.
9. Parinate C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatr. (2001) 49 391 404.
10. Stout S.C., Owens M.J., Nemeroff C.B. Regulation of corticotropin- releasing factor neuronal system and hypothalamic-pituitary adrenal axis activity by stress and chronic antidepressant treatment. J. Pharmacol. Exp Ther. (2002) 300 1085 1092.
11. Gold P.W., Goodwin F.K., Chrousoss G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress. N. Engl. J. Med. (1998) 319 348 353.
12. Nemeroff C.B. The corticotripin releasing factor hypothesis of depression: new findings and new direction. Mol. Psychiatr. (1996) 1 336 342.
13. Porsolt R.D., Bertin A., Jafre M. Behavioral despair in rats and mice: Reversal by antidepressants. Psychopharmacology (1977) 51 291 298.
14. Reddy D.S., Kulkarni S.K. Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment. Brain Res. (1998) 799 215 229.
15. Kulkarni S.K., Reddy D.S. Animal behavioral models for testing antianxiety agents. Methods Find. Exp. Clin. Pharmacol. (1996) 18 219 230.
16. Kulkarni S.K. Hand book of experimental pharmacology, 3rd edn, Vallabh Prakashan, Delhi, 1999, pp. 117 118.
17. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. J. Biochem. (1966) 99 667 676.
18. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. (1959) 82 70 77.
19. Green L.C., Wagner D.A., Glagowski J. Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal. Biochem. (1982) 126 131 138.
20. Lowry O.H., Rosenberg N.J., Farr A.L., Randall R.J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. (1951) 193 265 275.
21. Luck H. Catalase, in : Bergmeyer H.U. (Ed. Methods of enzymatic analysis, Academic Press, New York, 1971, pp. 885 893.
22. Wearden A.J., Appleby L. Research on cognitive complaints and cognitive functioning in patients with chronic fatigue syndrome: what conclusion can we draw? J. Psychosom. Res. (1996) 41 197 211.
23. Komaroof A.L. The biology of chronic fatigue syndrome. Am. J. Med. (2000) 108 169 171.
24. Glaser R., Kiecolt-Glaser J.K. Stress-associated immune modulation: relevance to viral infection and chronic fatigue syndrome. Am. J. Med. (1998) 105 27S 34S.
25. Clare A.J. The neuroendocrinology of chronic fatigue syndrome. Trends Endocrinol. Metab. (2004) 15 55 59.
26. Jones M.G., Goodwin S., Amjad S., Chalmer R.A. Plasma and urinary carnitine and acylacarnitines in Chronic fatigue syndrome. Clin. Chim. Acta (2005) 360 173 177.
27. Behan W.M.H., More I.A.R., Behan P.O. Mitochondrial abnormalities in the post viral fatigue syndrome. Acta Neuropathol. (1991) 83 61 65.
28. Papanicolaou D.A., Pertrides J.S., Tsigos C. et al. Exercise stimulates interleukin-6 secretion: inhibiton by glucorticoid and correlation with catecholamines. Am. J. Physiol. (1996) 271 E601 E605.
29. Goebel M.U., Mills P.J., Irwin M.R., Ziegler M.G. Interleukin-6 and TNF-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom. Med. (2000) 62 591 598.
30. Steptoe A., Willemsen G., Owen N., Flower L., Mohamed Ali V. Acute mental stress elicits delayed increase in circulating inflammatory cytokine levels. Clin. Sci. (2001) 101 185 192.
31. Lutgendorf S.K., Antonin M.H., Lironson G. et al. Physcial symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosom. Med. (1995) 57 310 323.
32. Sharpe M.C., Archard L.C., Banatvala J.E. A report-chronic fatigue syndrome: guidelines for research. J. R. Soc. Med. (1991) 84 118 121.
33. Yoshiuchi K. Psychological symptoms in chronic fatigue syndrome. Nippon Rinsho (2007) 65 1023 1027.
34. Afari N., Buchwald D. Chronic fatigue syndrome: a review. Am. J. Psychiatry (2003) 160 221 236.
35. Yoshimizu T., Shimazaki T., Ito A., Chaki S. An mGlu R2/3 antagonist, MG S0039, exert antidepressant and anxiolytic effects in behavioral models in rats. Psychopharmacology (2006) 186 586 593.
36. Izumi T., Inoue T., Kitacichi Y., Nakagawa S., Koyamam T. Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor. Eur. J. Pharmacol. (2006) 534 129 132.
37. Inoue T., Izumi T., Li X.B. et al. Biological basis of anxiety disorders and serotonergic anxiolytics. Nihon Shinkei Seishin Yakurigaku zasshi (2004) 24 125 131.
38. Cleare A.J. The neuroendcrinology of chronic fatigue syndrome. Endocr. Rev. (2003) 24 236 252.
39. Gaab J., Engert V., Heitza V., Schad T., Schurmeyer T.H., Ehlert U. Association between neuroendocrine response to insulin tolerance test and patient characteristics in chronic fatigue syndrome. J. Psychosom. Res. (2004) 56 419 424.
40. Nijs J., De Meirleir K. Oxidative stress might reduce essential fatty acids in enrythocyrte memberane of chronic fatigue syndrome patients. Nutr. Neurosci. (2004) 7 251 253.
41. Greenberg S., Frid M. Chronic fatigue syndrome - exercise and physical activity. Harefuah (2006) 145 276 280.
42. Schonfeldt-Locuona C., Connemann B.J., Wolf R.C., Braun M., Freudenmann R.W. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode. Pharmacopsychiatry (2006) 39 152 154.
43. Bounos G., Molson J. Competititon for glutathione precursor betwe3en the immune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome. Med. Hypotheses (1999) 53 347 349.
44. Poteliakhoff A. Adrenocortical activity and some clinical findings in acute and chronic fatigue. J. Psychosom. Res. (1981) 25 91 95.
45. Jerjes W.K., Peter T.J., Taylor N.F., Wood P.J., Wessely S., Cleare A.J. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. J. Psychosom. Res. (2006) 60 14 153.